Universal HBV Screening Is Cost-Effective in Lymphoma Medscape In patients who were going to receive rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy, screening all patients for HBV decreased the rate of HBV reactivation by 10-fold and was a less expensive option than ... |
